Dactoma®

Dactinomycin

Product Information

  • Proprietary Name: Dactoma®
  • Generic Name: Dactinomycin
  • Dosage Form: Vial
  • Strengths: 0.5 mg
  • Indications: Wilms Tumor, Rhabdomyosarcoma, Ewing Sarcoma, Testicular Cancer, Gestational Trophoblastic Neoplasia, Solid Malignancies

Oncology

Dactoma®

Dactinomycin is indicated for the treatment of wilms tumor, rhabdomyosarcoma, ewing sarcoma, testicular cancer, gestational trophoblastic neoplasia, and solid malignancies.

Ready to get started?

Curious about a specific position? Sign up for it.
© NanoAlvand. All rights reserved. Powered by ِDGN.